{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:11:17Z","timestamp":1791461477672,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.ejpb.2016.02.002","type":"journal-article","created":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T17:48:23Z","timestamp":1455040103000},"page":"103-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution\/permeation system reflecting the gastric dissolution process"],"prefix":"10.1016","volume":"101","author":[{"given":"Makoto","family":"Kataoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Fukahori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsumi","family":"Ikemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Higashino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2016.02.002_b0005","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7326\/0003-4819-114-9-755","article-title":"Increased gastric pH and the bioavailability of fluconazole and ketoconazole","volume":"114","author":"Blum","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejpb.2016.02.002_b0010","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijpharm.2015.06.019","article-title":"In vitro dissolution\u2013permeation evaluation of an electrospun cyclodextrin-based formulation of aripiprazole using \u03bcFlux\u2122","volume":"491","author":"Borb\u00e1s","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.02.002_b0015","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/jps.21576","article-title":"IVIVC in oral absorption for fenofibrate immediate release tablets using a dissolution\/permeation system","volume":"98","author":"Buch","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.02.002_b0020","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/jps.21525","article-title":"Biowaiver monographs for immediate release solid oral dosage forms: diclofenac sodium and diclofenac potassium","volume":"98","author":"Chuasuwan","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.02.002_b0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejpb.2007.01.017","article-title":"The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats","volume":"67","author":"Dahan","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.02.002_b0030","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/0091270005276738","article-title":"Dipyridamole bioavailability in subjects with reduced gastric acidity","volume":"45","author":"Derendorf","year":"2005","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2016.02.002_b0035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0378-5173(98)00330-5","article-title":"Prediction of dissolution\u2013absorption relationships from a dissolution\/Caco-2 system","volume":"177","author":"Ginski","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.02.002_b0040","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejps.2014.07.008","article-title":"Gastrointestinal transfer: in vivo evaluation and implementation in in vitro and in silico predictive tools","volume":"63","author":"Hens","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.02.002_b0045","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1021\/mp400465p","article-title":"In vitro\u2013in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs","volume":"11","author":"Higashino","year":"2014","journal-title":"Mol. Pharm."},{"issue":"Suppl 2","key":"10.1016\/j.ejpb.2016.02.002_b0050","doi-asserted-by":"crossref","first-page":"77S","DOI":"10.1111\/j.1365-2125.1985.tb02746.x","article-title":"The gastrointestinal absorption of drugs in man: a review of current concepts and methods of investigation","volume":"19","author":"Hirtz","year":"1985","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2016.02.002_b0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-5173(01)00897-3","article-title":"Simulated intestinal fluid as transport medium in the Caco-2 cell culture model","volume":"232","author":"Ingels","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.02.002_b0060","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijpharm.2004.01.014","article-title":"Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers","volume":"274","author":"Ingels","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.02.002_b0065","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2016.02.002_b0070","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejpb.2012.12.001","article-title":"An in vitro\u2013in silico\u2013in vivo approach to predicting the oral pharmacokinetic profile of salts of weak acids: case example dantrolene","volume":"84","author":"Kambayashi","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.02.002_b0075","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1023\/A:1026107906191","article-title":"In vitro system to evaluate oral absorption of poorly water-soluble drugs: simultaneous analysis on dissolution and permeation of drugs","volume":"20","author":"Kataoka","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2016.02.002_b0080","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/jps.20691","article-title":"Effect of food intake on the oral absorption of poorly water-soluble drugs: in vitro assessment of drug dissolution and permeation assay system","volume":"95","author":"Kataoka","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2016.02.002_b0085","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1248\/bpb.34.401","article-title":"In vitro dissolution\/permeation system to predict the oral absorption of poorly water-soluble drugs: effect of food and dose strength on it","volume":"34","author":"Kataoka","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2016.02.002_b0090","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11095-011-0623-2","article-title":"Application of dissolution\/permeation system for evaluation of formulation effect on oral absorption of poorly water-soluble drugs in drug development","volume":"29","author":"Kataoka","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2016.02.002_b0095","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.ejpb.2013.06.018","article-title":"Assessment of absorption potential of poorly water-soluble drugs by using the dissolution\/permeation system","volume":"85","author":"Kataoka","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.02.002_b0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0378-5173(01)00663-9","article-title":"Development of a new system for prediction of drug absorption that takes into account drug dissolution and pH change in the gastro-intestinal tract","volume":"221","author":"Kobayashi","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.02.002_b0105","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1211\/0022357991772277","article-title":"Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique","volume":"51","author":"Kohri","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2016.02.002_b0110","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","article-title":"Dantrolene \u2013 a review of its pharmacology, therapeutic use and new developments","volume":"59","author":"Krause","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ejpb.2016.02.002_b0115","first-page":"228","article-title":"Effect of food and gastric acidity on absorption of orally administered ketoconazole","volume":"7","author":"Lelawongs","year":"1988","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.ejpb.2016.02.002_b0120","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1021\/mp500210c","article-title":"Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state","volume":"11","author":"Mudie","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2016.02.002_b0125","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ejpb.2006.10.015","article-title":"Permeability assessment for solid oral drug formulations based on Caco-2 monolayer in combination with a flow through dissolution cell","volume":"66","author":"Motz","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2016.02.002_b0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2036.1990.tb00013.x","article-title":"Intravenous pentagastrin can induce the illusion of \u2019tolerance\u2019 to a single dose of an H2-blocker in man","volume":"1","author":"Nwokolo","year":"1990","journal-title":"Aliment. Pharmacol. Ther. Suppl."},{"key":"10.1016\/j.ejpb.2016.02.002_b0135","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1023\/A:1018918316253","article-title":"PH-related changes in the absorption of dipyridamole in the elderly","volume":"11","author":"Russell","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2016.02.002_b0140","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4269\/ajtmh.2000.63.270","article-title":"Effect of dose increase or cimetidine co-administration on albendazole bioavailability","volume":"63","author":"Schipper","year":"2000","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejpb.2016.02.002_b0145","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/clpt.2011.267","article-title":"Imaging of gastrointestinal absorption and biodistribution of an orally administered probe using positron emission tomography in humans","volume":"91","author":"Shingaki","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2016.02.002_b0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2010.07.027","article-title":"Computational oral absorption simulation of free base drugs","volume":"398","author":"Sugano","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2016.02.002_b0155","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/bdd.2510150905","article-title":"The bioavailability of diclofenac from enteric coated products in healthy volunteers with normal and artificially decreased gastric acidity","volume":"15","author":"Van Gelderen","year":"1994","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejpb.2016.02.002_b0160","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0163-7258(89)90019-3","article-title":"Effects of food on drug absorption","volume":"43","author":"Welling","year":"1989","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2016.02.002_b0165","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s11095-012-0931-1","article-title":"Measurement of drug concentration in the stomach after intragastric administration of drug solution to healthy volunteers: analysis of intragastric fluid dynamics and drug absorption","volume":"30","author":"Yamashita","year":"2013","journal-title":"Pharm. Res."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116300042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641116300042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T10:19:36Z","timestamp":1748773176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641116300042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":33,"alternative-id":["S0939641116300042"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.02.002","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution\/permeation system reflecting the gastric dissolution process","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2016.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}